封面
市场调查报告书
商品编码
1741473

高阶CELLOMICS市场:按产品类型、按应用、按技术、按最终用户、按地区

High End Cellomics Market, By Product Type, By Application, By Technology, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3个工作天内

价格
简介目录

高端CELLOMICS市场规模预计在 2025 年达到 46.4 亿美元,预计到 2032 年将达到 85.4 亿美元,2025 年至 2032 年的年复合成长率(CAGR)为 9.1%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 46.4亿美元
效能数据 2020-2024 预测期 2025-2032
预测期:2025-2032年复合年增长率: 9.10% 2032年价值预测 85.4亿美元

高端CELLOMICS市场正经历强劲成长,并已成为细胞分析和研究领域的焦点。高端CELLOMICS是指用于在分子层面上研究细胞的先进技术和仪器。这些技术使科学家和研究人员能够分析细胞的结构、功能和动态,从而推动药物研发、疾病诊断和个人化医疗等各个领域取得重要进展。

随着基于细胞的研究需求日益增长,以及对细胞过程进行精准分析的需求日益增长,高端CELLOMICS日益受到关注。高解析度显微镜和高内涵筛检等成像技术的进步,为高端CELLOMICS市场的成长做出了巨大贡献。此外,人工智慧和机器学习演算法的融合,彻底改变了复杂细胞数据的分析和解读方式。

市场动态:

高端CELLOMICS市场受到多种因素驱动,包括对个人化医疗日益增长的需求以及对药物研发和市场开发的日益关注。癌症和心血管疾病等慢性疾病的发生率不断上升,进一步推动了对先进细胞分析技术的需求。此外,製药和生技公司对研发活动的投入也为市场发展做出了重大贡献。

例如,2023年10月26日,研究和科技公司A4cell宣布一项310万美元的重大投资。这项重大投资将成为彻底改变活体单细胞分析领域的催化剂。这项投资将主要用于加强研发力度,引进高技能的科学家和工程师,并加速开发旨在揭示活体单细胞奥秘的最尖端科技。

然而,高端CELLOMICS市场也面临一些挑战。采购和维护先进细胞分析设备的高成本阻碍了市场发展,尤其是在新兴市场。此外,缺乏能够处理和分析复杂细胞数据的专家,也阻碍了高端CELLOMICS技术的广泛应用。

儘管面临诸多挑战,高端CELLOMICS市场仍蕴藏着许多成长机会。单细胞定序和空间转录组学等新型细胞分析技术的出现,为进一步探索和理解细胞机制铺平了道路。此外,多体学资料分析的整合以及创新成像模式的开发,也为市场拓展提供了广阔的机会。

本研究的主要特点

  • 本报告对全球高端CELLOMICS市场进行了详细分析,包括其市场规模和预测期为 2025 年至 2032 年的复合年增长率(以 2024 年为基准年)。
  • 它揭示了不同细分市场中的潜在收益成长机会,并为高端CELLOMICS市场提供了一系列有吸引力的投资提案。
  • 它提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及高端CELLOMICS市场主要企业采用的竞争策略的主要考察。
  • 本报告介绍了全球高端CELLOMICS市场的主要企业,包括其公司背景、产品系列、主要成就、财务表现和策略。
  • 参与的主要公司包括赛默飞世尔科技、丹纳赫、珀金埃尔默、BD、Bio-Rad Laboratories、安捷伦主要企业、Illumina、Luminex、默克集团、通用电气医疗集团、布鲁克、NanoString Technologies、10x Genomics、Fluidigm、Celsi、Berkeley Flus、Genpnaics Flus、美天掟ics、BioOronl、Hornaics、Yetc​​k照
  • 报告中的见解将使负责人和经营团队能够就产品发布、升级、市场扩张和行销策略做出明智的决策。
  • 本报告针对高端CELLOMICS市场的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员将受益于用于分析全球高端CELLOMICS市场的策略矩阵,从而更容易做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
  • 个人化医疗需求日益增长
  • 采购和维护先进细胞分析设备的高成本
  • 单细胞定序与空间转录组学等新细胞分析技术的出现
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

4. 全球高阶CELLOMICS市场-冠状病毒(COVID-19)大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 2020 年至 2032 年全球高阶CELLOMICS市场(依产品类型)

  • 装置
  • 试剂和耗材
  • 软体
  • 服务

6. 全球高端CELLOMICS市场(按应用),2020 年至 2032 年

  • 药物研发
  • 癌症研究
  • 神经科学
  • 干细胞研究与再生医学
  • 个人化医疗
  • 其他的

7. 2020 年至 2032 年全球高端CELLOMICS市场(按技术划分)

  • 显微镜
  • 流式细胞技术
  • 单细胞基因体学
  • 质谱法
  • 次世代定序
  • 其他的

8. 2020 年至 2032 年全球高阶CELLOMICS市场(依最终使用者划分)

  • 生物技术和製药公司
  • 医院和诊断实验室
  • 受託研究机构
  • 其他的

9. 全球高端CELLOMICS市场(按地区),2020 年至 2032 年

  • 北美洲
      • 美国
      • 加拿大
  • 欧洲
      • 英国
      • 德国
      • 义大利
      • 法国
      • 西班牙
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 日本
      • 印度
      • ASEAN
      • 澳洲
      • 韩国
      • 其他亚太地区
  • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他拉丁美洲
  • 中东
      • GCC
      • 以色列
      • 其他中东地区
  • 非洲
      • 北非
      • 中部非洲
      • 南非

第十章 竞争格局

  • Thermo Fisher Scientific
  • Danaher
  • PerkinElmer
  • BD
  • Bio-Rad Laboratories
  • Agilent Technologies
  • Illumina
  • Luminex
  • Merck KGaA
  • GE Healthcare
  • Bruker
  • Nanostring Technologies
  • 10x Genomics
  • Fluidigm
  • Celsee
  • Berkeley Lights
  • Miltenyi Biotec
  • Bionano Genomics
  • Bio-Techne
  • Sphere Fluidics

第 11 章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6303

High End Cellomics Market is estimated to be valued at USD 4.64 Bn in 2025 and is expected to reach USD 8.54 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 4.64 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.10% 2032 Value Projection: USD 8.54 Bn

The high end cellomics market is experiencing significant growth and has become a key focus area in the field of cellular analysis and research. High end cellomics refers to the advanced technologies and instruments used for the study of cells at a molecular level. These technologies enable scientists and researchers to analyze cell structure, function, and dynamics, leading to important advancements in various fields such as drug discovery, disease diagnosis, and personalized medicine.

High end cellomics has gained prominence due to the increasing demand for cell-based research and the need for precise and accurate analysis of cellular processes. Advancements in imaging technologies, such as high-resolution microscopy and high-content screening, have greatly contributed to the growth of the high end cellomics market. Additionally, the integration of artificial intelligence and machine learning algorithms have revolutionized the analysis and interpretation of complex cellular data.

Market Dynamics:

The high end cellomics market is driven by several factors including the increasing demand for personalized medicine and the growing focus on drug discovery and development. The rising prevalence of chronic diseases, such as cancer and cardiovascular disorders, further fuels the demand for advanced cell analysis technologies. Additionally, investments in research and development activities by pharmaceutical and biotechnology companies have significantly contributed to the market growth.

For instance, on October 26, 2023, A4cell, a research and technology company, announced a significant US$ 3.1 million investment. This significant investment will act as a catalyst to completely transform the field of live single-cell analysis. The investment will mainly go towards stepping up R&D efforts, growing their highly skilled staff of scientists and engineers, and quickening the development of cutting-edge technologies intended to reveal the mysteries concealed in live single cells.

However, the high end cellomics market also faces certain challenges. The high costs associated with the procurement and maintenance of advanced cell analysis instruments poses a barrier to market growth, especially in developing regions. Moreover, the lack of skilled professionals proficient in handling and analyzing complex cellular data hampers the widespread adoption of high end cellomics technologies.

Despite these challenges, the high end cellomics market presents numerous opportunities for growth. The emergence of new cellular analysis techniques, such as single-cell sequencing and spatial transcriptomics, opens avenues for further exploration and understanding of cellular mechanisms. Additionally, the integration of multi-omics data analysis and the development of innovative imaging modalities offer promising opportunities for market expansion.

Key Features of the Study:

  • This report provides an in-depth analysis of the global high end cellomics market including its market size (in US$ Bn) and compound annual growth rate (CAGR %) over the forecast period of 2025-2032, with 2024 as the base year
  • It elucidates potential revenue growth opportunities across different market segments and provides attractive investment proposition matrices for the high end cellomics market
  • The study offers key insights into market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players in the high end cellomics market
  • It profiles key players in the global high end cellomics market, highlighting their company backgrounds, product portfolios, key achievements, financial performance, and strategies
  • The report includes a comprehensive list of key companies covered in the study including Thermo Fisher Scientific, Danaher, PerkinElmer, BD, Bio-Rad Laboratories, Agilent Technologies, Illumina, Luminex, Merck KGaA, GE Healthcare, Bruker, Nanostring Technologies, 10x Genomics, Fluidigm, Celsee, Berkeley Lights, Miltenyi Biotec, Bionano Genomics, Bio-Techne, and Sphere Fluidics
  • Insights from this report will enable marketers and management authorities to make informed decisions regarding product launches, upgrades, market expansion, and marketing strategies
  • The report caters to various stakeholders in the high end cellomics market including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders will benefit from the strategy matrices used in the analysis of the global high end cellomics market, facilitating ease in decision-making

High End Cellomics Market Segmentation:

  • By Product Type
    • Instruments
    • Reagents and Consumables
    • Software
    • Services
  • By Application
    • Drug discovery
    • Cancer Research
    • Neuroscience
    • Stem Cell Research and Regenerative Medicine
    • Personalized Medicine
    • Others
  • By Technology
    • Microscopy
    • Flow Cytometry
    • Single-cell Genomics
    • Mass Spectrometry
    • Next Generation Sequencing
    • Others
  • By End User
    • Biotechnology & Pharmaceutical Companies
    • Hospitals & Diagnostic Laboratories
    • Contract Research Organizations
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • Thermo Fisher Scientific
    • Danaher
    • PerkinElmer
    • BD
    • Bio-Rad Laboratories
    • Agilent Technologies
    • Illumina
    • Luminex
    • Merck KGaA
    • GE Healthcare
    • Bruker
    • Nanostring Technologies
    • 10x Genomics
    • Fluidigm
    • Celsee
    • Berkeley Lights
    • Miltenyi Biotec
    • Bionano Genomics
    • Bio-Techne
    • Sphere Fluidics

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global High End Cellomics Market, By Product Type
    • Global High End Cellomics Market, By Application
    • Global High End Cellomics Market, By Technology
    • Global High End Cellomics Market, By End User
    • Global High End Cellomics Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing demand for personalized medicine
    • Restraints
  • High costs associated with the procurement and maintenance of advanced cell analysis instruments
    • Opportunities
  • Emergence of new cellular analysis techniques such as single-cell sequencing and spatial transcriptomics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global High End Cellomics Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global High End Cellomics Market, By Product Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Reagents & Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Software
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global High End Cellomics Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Drug discovery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Cancer Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Neuroscience
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Stem Cell Research and Regenerative Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Personalized Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global High End Cellomics Market, By Technology, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Microscopy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Flow Cytometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Single-cell Genomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Mass Spectrometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Next Generation Sequencing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global High End Cellomics Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Biotechnology & Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Hospitals & Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Contract Research Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Global High End Cellomics Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
      • China
      • Japan
      • India
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020 - 2032, (US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Danaher
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • PerkinElmer
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BD
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Agilent Technologies
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Illumina
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Luminex
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • GE Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bruker
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nanostring Technologies
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • 10x Genomics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Fluidigm
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Celsee
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Berkeley Lights
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Miltenyi Biotec
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bionano Genomics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bio-Techne
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sphere Fluidics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us